CELLDEX THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.66 USD | +1.87% |
|
-2.69% | +2.19% |
| 05-06 | Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q1 Revenue $156,000 | MT |
| 05-06 | Celldex Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CELLDEX THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +1.55% | -2.69% | +2.19% | +18.30% | +1,203.22% | 2.63B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- CLDX Stock
- Charts Celldex Therapeutics, Inc.
- Comparison Chart
